¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"RNA 5' Terminal Oligopyrimidine Sequence"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gradient echo pulse sequence
    ±â¿ï±â¸Þ¾Æ¸®ÆÞ½º¿¬¼â
  • inversion recovery pulse sequence
    ¿ªÀüȸº¹ÆÞ½º¿¬¼â
  • imaging sequence
    ¿µ»ó¿¬¼â
  • insertion sequence
    »ðÀÔ¼­¿­
  • intervening sequence
    °³Àç¼ø¼­
  • oligohydroamnios sequence
    ¾ç¼ö°ú¼ÒÁõ¿¬¼â
  • pulse sequence
    ¹Úµ¿¿¬¼â, ÆÞ½º¿¬¼â
  • packaging sequence
    ²Ù¸®±â¼ø¼­
  • rapid-sequence induction
    ºü¸¥¿¬¼Ó¸¶ÃëÀ¯µµ
  • rapid-sequence intubation
    ºü¸¥¿¬¼Ó±â°ü»ð°ü
  • reaction sequence
    ¹ÝÀÀ¼ø¼­
  • respiratory sequence
    È£Èí¼ø¼­
  • radio frequency pulse sequence
    °íÁÖÆÄÆÞ½º¿¬¼â
  • spin echo pulse sequence
    ½ºÇÉ¿¡ÄÚÆÞ½º¿¬¼â
  • steady state coherent sequence
    Ç×Á¤»óŰáÁý¿¬¼â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • flow compensated pulse sequence
    È帧º¸»óÆÞ½º¿¬¼â
  • flow sensitive gradient echo sequence
    È帧¹Î°¨±â¿ï±â¸Þ¾Æ¸®¿¬¼â
  • gradient echo pulse sequence
    ±â¿ï±â¸Þ¾Æ¸®ÆÞ½º¿¬¼â
  • imaging sequence
    ¿µ»ó¿¬¼â
  • insertion sequence
    »ðÀÔ¼­¿­
  • intervening sequence
    (¢¡intron) ÀÎÆ®·Ð
  • inversion recovery pulse sequence
    ¿ªÀüȸº¹ÆÞ½º¿¬¼â
  • rapid-sequence induction
    ºü¸¥¿¬¼Ó¸¶ÃëÀ¯µµ
  • rapid-sequence intubation
    ºü¸¥¿¬¼Ó±â°ü»ð°ü
  • mixed sequence
    º¹ÇÕ¿¬¼â
  • oligohydroamnios sequence
    ¾ç¼ö°ú¼Ò¼ø¼­
  • packaging sequence
    ²Ù¸®±â¼ø¼­
  • partial saturation spin echo sequence
    ºÎºÐÆ÷È­½ºÇɸ޾Ƹ®¿¬¼â
  • pulse sequence
    ¹Úµ¿¿¬¼â, ÆÞ½º¿¬¼â
  • radio-frequency pulse sequence
    °íÁÖÆÄÆÞ½º¿¬¼â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • porters sequence
    Æ÷ÅÍ¿¬¼â(¡­ææáð), Æ÷Å͹迭¼ø(¡­ÛÕÖªâ÷)
  • pulse sequence
    ¹Úµ¿ ¿¬¼â, ÆÞ½º ¿¬¼â
  • radio-frequency pulse sequence
    °íÁÖÆÄ ÆÞ½º ¿¬¼â
  • reaction sequence
    ¹ÝÀÀ¼ø¼­.
  • DNA polymerase, RNA dependent
    RNA- ÀÇÁ¸ DNA ÁßÇÕÈ¿¼Ò
  • DNA polymerase, RNA-dependent
    RNA-ÀÇÁ¸ DNA ÁßÇÕÈ¿¼Ò
  • DNA-RNA hybridization
    DNA-RNA ¦Áö¿ì±â, DNA-RNA ºÎÇÕ°Ë»ç¹ý(ݬùê~)
  • DNA-dependent RNA polymerase
    DNA-ÀÇÁ¸ DNA ÁßÇÕÈ¿¼Ò
  • DNA-dependent RNA polymerase
    DNA-ÀÇÁ¸ RNA ÁßÇÕÈ¿¼Ò
  • RNA =>ribonucleic acid
    ¸®º¸ÇÙ»ê
  • RNA editing
    RNA ±³Á¤
  • RNA polymerase
    RNA ÁßÇÕÈ¿¼Ò
  • RNA polymerase I
    RNA ÁßÇÕÈ¿¼Ò I
  • RNA recombination
    RNA Àç°áÇÕ
  • RNA splicing
    RNA ½ºÇöóÀ̽Ì, RNA Àç´Ü, RNA Â¥±é±â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ribonucleic acid =RNA
    ¸®º¸ÇÙ»ê (¡­ú·ß«).
  • ribosomal RNA
    ¸®º¸¼Ø¸®º¸ÇÙ»ê(¡­ú·ß«).
  • rna oncogenic virus
    RNA(¸®º¸ÇÙ»ê)¹ß¾Ï¼º ¹ÙÀÌ·¯½º(Û¡äßàõ¡­)
  • subgenomic RNA
    ¾ÆÁö³ð RNA
  • subgenomic m-RNA
    ¾ÆÁö³ð mRNA
  • transfer RNA
    ÀüÀÌ RNA
  • adenoma-carcinoma sequence
    ¼±Á¾-¾ÏÁ¾ ¿¬¼â(àÍðþ-äßðþ ææáð)
  • amino acid sequence
    ¾Æ¹Ì³ë»ê ¼­¿­.
  • breech disruption sequence
  • delta sequence
    µ¨Å¸ ¼­¿­
  • driven equilibrium Fourier transform sequence
    ÃßÁø ÆòÇü Fourier º¯È¯ ¿¬¼â
  • echo train sequence
    ¿¡ÄÚ ¿­ ¿¬¼â
  • fast multiplanar spoiled gradient recalled sequence
    °í¼Ó ´Ù¸é ȸ¼Õ °æ»ç ȸº¹ ¿¬¼â
  • flow compensated pulse sequence
    À¯µ¿ º¸»ó ÆÞ½º ¿¬¼â
  • flow sensitive gradient echo sequence
    À¯µ¿ ¹Î°¨ °æ»ç ¿¡ÄÚ ¿¬¼â
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Palisade terminal
    ¿ïŸ¸®Á¾¸»
    [¿¾ ¿ë¾î] Ã¥»óÁ¾¸»
  • Primitive terminal plate
    ¿ø½ÃÁ¾¸»ÆÇ
    [¿¾ ¿ë¾î] ¿ø½ÃÁ¾ÆÇ
  • Free nerve terminal
    ÀÚÀ¯½Å°æÁ¾¸»
    [¿¾ ¿ë¾î] ÀÚÀ¯½Å°æÁ¾¸»
  • Terminal ventricle
    Á¾¸»³ú½Ç
    [¿¾ ¿ë¾î] Á¾½Ç
  • Terminal bulb
    Á¾¸»¸Á¿ï
    [¿¾ ¿ë¾î] Á¾¸»±¸
  • Terminal capillary
    Á¾¸»¸ð¼¼Ç÷°ü
    [¿¾ ¿ë¾î] Á¾¸»¸ð¼¼Ç÷°ü
  • Terminal foot
    Á¾¸»¹ß
    [¿¾ ¿ë¾î] Á¾¸»Á·
  • Terminal portion
    Á¾¸»ºÎºÐ
    [¿¾ ¿ë¾î] Á¾¸»ºÎ
  • Terminal portion
    Á¾¸»ºÎÀ§
    [¿¾ ¿ë¾î] Á¾¸»ºÎ
  • Terminal portion
    Á¾¸»ºÎÀ§
    [¿¾ ¿ë¾î] Á¾¸»ºÐºñºÎ
  • Terminal bronchiole
    Á¾¸»¼¼±â°üÁö
    [¿¾ ¿ë¾î] Á¾¸»¼¼±â°üÁö
  • Terminal cistern
    Á¾¸»¼öÁ¶
    [¿¾ ¿ë¾î] Á¾¸»¼ÒÁ¶
  • Terminal calyx
    Á¾¸»¼úÀÜ
    [¿¾ ¿ë¾î] Á¾¸»¹è
  • Terminal nerve
    Á¾¸»½Å°æ
    [¿¾ ¿ë¾î] Á¾½Å°æ
  • Terminal corpuscle
    Á¾¸»½Å°æ¼Òü
    [¿¾ ¿ë¾î] ½Å°æÁ¾¸»¼Òü
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • terminal transferase
    ¸»´Ü(ØÇÓ®) Æ®·£½ºÆÛ·¹À̽º
  • Alu sequence
    Alu ¼­¿­(ßíæê)
  • amino acid sequence
    ¾Æ¹Ì³ë»ê(ß«) ¼­¿­(ßíæê)
  • base sequence
    ¿°±â¼­¿­(ç¤ÐñßíÖª)
  • chi sequence
    Ä«ÀÌ ¼­¿­(ßíÖª)
  • complementary base sequence
    »óº¸¼º ¿°±â¼­¿­(ßÓÜÍàõç¤ÐñßíÖª)
  • consensus sequence
    °øÅë¼­¿­(Íì÷×ßíÖª)
  • conserved sequence
    º¸Á¸(ÜÁðí) ¼­¿­(ßíÖª)
  • core sequence
    Çٽɼ­¿­(ú·ãýßíÖª)
  • effector sequence
    È¿°ú±â ¼­¿­(üùÍýÐïßíÖª)
  • identifier sequence
    ÀνÄÀÚ ¼­¿­(ìããÛí­ßíÖª)
  • IDP sequence
    IDP ¼­¿­(ßíÖª)
  • intervening sequence
    °³Àç¼­¿­(Ë¿î¤ßíÖª)
  • leader sequence
    ¼±µµ¼­¿­(à»ÓôßíÖª)
  • leader sequence peptide
    ¼±µµ¼­¿­(à»ÓôßíÖª) ÆéŸÀ̵å
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • imaging sequence
    ¿µ»ó¿¬¼â
  • inversion recovery pulse sequence
    ¿ªÀüȸº¹ÆÞ½º¿¬¼â
  • mixed sequence
    º¹ÇÕ¿¬¼â
  • multislice FLASH sequence
    ´ÙÀýÆíFLASH¿¬¼â
  • partial saturation spin echo sequence
    ºÎºÐÆ÷È­½ºÇÉ¿¡ÄÚ¿¬¼â
  • pulse sequence
    ¹Úµ¿¿¬¼â, ÆÞ½º¿¬¼â
  • radio-frequency pulse sequence
    °íÁÖÆÄÆÞ½º¿¬¼â
  • RF pulse sequence
    °íÁÖÆÄÆÞ½º¿¬¼â
  • sequence
    ¿¬¼â, ¹è¿­¼ø(¼­)
  • sequence
    ¿¬¼â, ¿¬¼Ó
  • spin echo pulse sequence
    ½ºÇÉ¿¡ÄÚÆÞ½º¿¬¼â
  • steady state coherent sequence
    Ç×Á¤»óŰáÁý¿¬¼â
  • ultra fast sequence
    Ãʰí¼Ó¿¬¼â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
TML terminal midline; terminal motor latency; tetramethyl lead
RNA Ribo-Nucleic Acid
HARS histidyl-RNA synthetase
poly-IC, poly-I:C copolymer of polyinosinic and polycytidylic acids; synthetic RNA polymer
RNA radionuclide angiography; Registered Nurse Anesthetist; ribonucleic acid; rough, noncapsulated, avir...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
RDRP RNA dependent RNA polymerase
sat RNA satellite RNA
n-RNA nuclear RNA
C-terminal carboxy terminal
ACS ARS consensus sequence
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • nerve terminal
    ½Å°æ Á¾¸»
  • nociceptor terminal
    Ä§ÇØ ¼ö¿ëü ¸»´Ü, À¯ÇØ ¼ö¿ë±â ¸»´Ü
  • primary afferent terminal
    ÀÏÂ÷ ±¸½É¼º ¸»´Ü
  • reticulothalamic terminal
    ¸Á»ó ½Ã»ó ¸»´Ü
  • spinothalamic terminal
    ô¼ö ½Ã»ó Á¾¸»
  • terminal axon
    ¸»´Ü Ãà»è
  • terminal bones
    Æó¼âÁ¦, Á¢ÇÕÁ¦
    »óÇÇ ¼¼Æ÷ÀÇ À¯¸® ¸éÀ» ¼­·Î Á¢Âø½ÃŰ´Â °áÇÕ ±¸Á¶ ȤÀº Á¢Âø´ë.
  • terminal bronchiol
    Á¾¸» ¼¼±â°üÁö, ¸»´Ü ¼¼°üÁö
  • terminal closing clicking joint noise
    Æó±¸ ¸»±âÀÇ ´Ü¼ø °üÀý ÀâÀ½
  • terminal field
    ¸»´ÜºÎ
  • terminal hinge axis
    Á¾¸» Á¢¹øÃà
    µ¿ÀǾî=transverse horizontal axis.
  • terminal hinge position
    Á¾¸» Á¢¹øÀ§
    ±³ÇÕÀÇ °í°æ°ú Áß½ÉÀ§¿¡¼­ Çü¼ºµÇ´Â ÇϾÇÀÇ »ó¾Ç¿¡ ´ëÇÑ °ü°è ±â·ÏÀÌ´Ù.
  • terminal ileum
    ȸÀå ¸»´ÜºÎ
  • terminal occlusion
    ÃÖÁ¾ ±³ÇÕ
    Æò¸éÀû Á¢ÃË ¶Ç´Â ±³ÇÕÀÌ ÃÖ´ëÇÑÀ¸·Î µÇ´Â ´ëÇÕÄ¡ÀÇ ±³Çո鰣 °ü°è.
  • terminal pattern
    ¸»´Ü ÇüÅÂ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
molecular sequence data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as genbank, european molecular biology laboratory (embl), national biomedical research foundation (nbrf), or other sequence repositories.
(12 Dec 1998)
coding sequence The portion of DNA that codes for transcription of messenger RNA.
See: exon.
(05 Mar 2000)
monotonic sequence A sequence in which each value in a set is greater than the preceding value.
(05 Mar 2000)
complementary sequence <molecular biology> Nucleicacid base sequences that can form a double-stranded structure bymatching base pairs, the complementary sequence to G-T-A-C is C-A-T-G.
(09 Oct 1997)
consensus sequence Of a series of related DNA, RNA or protein sequences, the sequence that reflects the most common choice of base or amino acid at each position. Areas of particularly good agreement often represent conserved functional domains. The generation of consensus sequences has been subjected to intensive mathematical analysis.
(18 Nov 1997)
conserved sequence <molecular biology> A base sequence in a DNA molecule (or an amino acid sequence in a protein) that has remained essentially unchanged throughout evolution.
(10 Nov 1998)
sequence The noun: the order in which subunits appear in a chain, such as amino acids in a polypeptide or nucleotide bases in a DNA or RNA molecule.
The verb: To find out in what order the subunits appear in the chain.
(09 Oct 1997)
sequence alignment The arrangement of two or more amino acid or base sequences from an organism or organisms in such a way as to align areas of the sequences sharing common properties. The degree of relatedness or homology between the sequences is predicted computationally or statistically based on weights assigned to the elements aligned between the sequences. This in turn can serve as a potential indicator of the genetic relatedness between the organisms.
(12 Dec 1998)
sequence analysis A multistage process that includes the determination of a sequence (protein, carbohydrate, etc.), its fragmentation and analysis, and the interpretation of the resulting sequence information. This information is useful in that it: 1) reveals the similarities of homologous genes, thereby providing insight into the possible regulation and functions of these genes; and 2) leads to a better understanding of disease states related to genetic variation. New sequencing methodologies, fully automated instrumentation, and improvements in sequencing-related computational resources contribute to the potential for genome-size sequencing projects.
(12 Dec 1998)
sequence analysis, DNA A multistage process that includes DNA cloning, physical mapping, subcloning, sequencing, and information analysis. New technological advances have led to the automation of certain steps in this process and contribute to the potential for large-scale DNA sequencing efforts.
(12 Dec 1998)
sequence, complementary Nucleic acid sequence of bases that can form a double- stranded structure by matching base pairs. For example, the complementary sequence to c-a-t-g (where each letter stands for one of the bases in DNA) is g-t-a-c.
(12 Dec 1998)
sequence, conserved A base sequence in a DNA molecule (or an amino acid sequence in a protein) that has remained essentially unchanged throughout evolution.
(12 Dec 1998)
sequence deletion Deletion of sequences of bases or amino acids from the genetic material of an individual. Evidence for these deletions may be obtained by cytological methods.
(12 Dec 1998)
sequence homology <molecular biology> Strictly, refers to the situation where nucleic acid or protein sequences are similar because they have a common evolutionary origin. Often used loosely to indicate that sequences are very similar. Sequence similarity is observable, homology is an hypothesis based on observation.
(18 Nov 1997)
sequence homology, amino acid The degree of similarity between sequences of amino acids. This information is useful for the understanding of genetic relatedness of certain species.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • editing terminal
    (Àü»ê)ÆíÁý ´Ü¸» ÀåÄ¡(TextÆíÁý¿ë ÄÄÇ»ÅÍ ÀÔÃâ·Â ÀåÄ¡)
  • freight terminal
    È­¹° Á¶Â÷Àå
  • home terminal
    °¡Á¤¿ë ´Ü¸»±â
  • intelligent terminal
    (Àü»ê)ÀÎÅÚ¸®ÀüÆ® ´Ü¸»±â(ÀÚ·áÀÇ ÀÔÃâ·Â ¿Ü¿¡ ÆíÁý,¿¬»ê,Á¦¾îµî ¾î´À Á¤µµÀÇ Ã³¸®´É·ÂÀ» °¡Áø°Í)
  • terminal
    ³¡ÀÇ;¸¶Áö¸·ÀÇ;Á¾Á¡ÀÇ(a ~ station Á¾Âø¿ª);Á¤±âÀÇ;ÇбâÀÇ
  • terminal
    ¸»´Ü;Á¾Âø¿ª;´ÜÀÚ;Çб⸻ ½ÃÇè;(ÄÄÇ»ÅÍ) ´Ü¸»ÀåÄ¡
  • terminal voltage
    ±ØÀü¾Ð
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á